Capital Analysts, LLC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 40 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Capital Analysts, LLC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$30.0%2,0000.0%0.00%
Q2 2023$30.0%2,0000.0%0.00%
Q1 2023$30.0%2,0000.0%0.00%
Q4 2022$3
-99.9%
2,0000.0%0.00%
Q3 2022$3,0000.0%2,0000.0%0.00%
Q2 2022$3,0000.0%2,0000.0%0.00%
Q1 2022$3,000
+50.0%
2,0000.0%0.00%
Q4 2021$2,000
-33.3%
2,0000.0%0.00%
Q3 2021$3,0000.0%2,0000.0%0.00%
Q2 2021$3,0000.0%2,0000.0%0.00%
Q1 2021$3,0000.0%2,0000.0%0.00%
Q4 2020$3,0000.0%2,0000.0%0.00%
Q3 2020$3,0000.0%2,0000.0%0.00%
Q2 2020$3,0000.0%2,0000.0%0.00%
Q1 2020$3,0000.0%2,0000.0%0.00%
Q4 2019$3,000
+50.0%
2,0000.0%0.00%
Q3 2019$2,000
-33.3%
2,0000.0%0.00%
Q2 2019$3,000
+50.0%
2,0000.0%0.00%
Q1 2019$2,0000.0%2,0000.0%0.00%
Q4 2018$2,000
-99.9%
2,000
-50.0%
0.00%
Q3 2018$3,412,0004,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aequim Alternative Investments LP 24,000,000$30,877,0005.11%
Alken Asset Management Ltd 360,000$457,0001.90%
III Capital Management 3,500,000$4,481,0001.64%
SHENKMAN CAPITAL MANAGEMENT INC 3,920,000$5,113,0000.76%
CSS LLC/IL 6,842,000$8,745,0000.69%
DeepCurrents Investment Group LLC 10,408,000$13,373,0000.65%
SSI INVESTMENT MANAGEMENT LLC 4,334,000$5,554,0000.49%
WOLVERINE ASSET MANAGEMENT LLC 18,250,000$23,476,0000.34%
MACKAY SHIELDS LLC 24,612,000$31,641,0000.29%
Nicholas Investment Partners, LP 1,115,000$1,429,0000.28%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders